174 related articles for article (PubMed ID: 26828143)
21. Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma.
Suman P; Wang CH; Moo-Young TA; Prinz RA; Winchester DJ
Am Surg; 2016 Sep; 82(9):807-14. PubMed ID: 27670568
[TBL] [Abstract][Full Text] [Related]
22. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma.
Licht K; Kroegel C; Katenkamp K; Freesmeyer M
Clin Nucl Med; 2016 Apr; 41(4):336-7. PubMed ID: 26571446
[TBL] [Abstract][Full Text] [Related]
23. Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
Marti JL; Davies L; Haymart MR; Roman BR; Tuttle RM; Morris LG
Thyroid; 2015 Jul; 25(7):865-6. PubMed ID: 25963001
[No Abstract] [Full Text] [Related]
24. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
Rosario PW
Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
[No Abstract] [Full Text] [Related]
25. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
[No Abstract] [Full Text] [Related]
26. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
Anongpornjossakul Y; Utamakul C; Chamroonrat W; Kositwattanarerk A; Thamnirat K; Sritara C
Clin Nucl Med; 2016 Mar; 41(3):e162-3. PubMed ID: 26447377
[TBL] [Abstract][Full Text] [Related]
27. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
Pavithran K; Doval DC
Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
[TBL] [Abstract][Full Text] [Related]
28. Unusual Granular Cell Tumor of the Trachea Coexisting With Papillary Thyroid Carcinoma and Masquerading as Tracheal Invasion of Recurred Thyroid Carcinoma: A Case Report.
Lee DH; Yoon TM; Lee JK; Lim SC
Medicine (Baltimore); 2016 May; 95(18):e3547. PubMed ID: 27149467
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
30. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
31. Differentiated thyroid carcinoma referred for radioiodine therapy.
Al-Balawi IA; Meir HM; Yousef MK; Nayel HA; Al-Mobarak MF
Saudi Med J; 2001 Jun; 22(6):497-503. PubMed ID: 11426239
[TBL] [Abstract][Full Text] [Related]
32. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
33. Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.
Teunissen JJ; Kwekkeboom DJ; Kooij PP; Bakker WH; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():107S-14S. PubMed ID: 15653659
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
35. Diffuse pulmonary metastases with negative ¹⁸FDG positron emission tomography/computed tomography and positive post-radioiodine therapy scan of papillary thyroid cancer.
Lin YS; Liang ZY; Qiu LH; Cheng X
Chin Med J (Engl); 2012 Jan; 125(1):153-6. PubMed ID: 22340484
[TBL] [Abstract][Full Text] [Related]
36. A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.
Ben Ghachem T; Yeddes I; Meddeb I; Bahloul A; Mhiri A; Slim I; Ben Slimene MF
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):655-660. PubMed ID: 27225282
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer.
Pitoia F; Bueno F; Cross G
Clin Nucl Med; 2014 Sep; 39(9):784-90. PubMed ID: 24999689
[TBL] [Abstract][Full Text] [Related]
38. [Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
Sun YG; Feng HJ; Liu JH; Hu R; Ouyang W
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1571-4. PubMed ID: 21945769
[TBL] [Abstract][Full Text] [Related]
39. Endotracheal Leiomyoma Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Papillary Thyroid Carcinoma.
Hwang JP; Lee SW; Kwak JJ; Park JM
Clin Nucl Med; 2017 Sep; 42(9):e403-e404. PubMed ID: 28639955
[TBL] [Abstract][Full Text] [Related]
40. An intrapericardial ectopic thyroid mimicking metastasis in a patient with papillary thyroid cancer: Localization, differential diagnosis by
Park SH; Seo M; Park TY; Nam-Goong S
Hell J Nucl Med; 2016; 19(3):272-274. PubMed ID: 27824968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]